Pathogen type | Examples | Target antigen(s) | Anchor | Vaccine development status | Applications | Ref |
---|---|---|---|---|---|---|
Viruses | SARS-CoV-2 | Receptor binding domain (RBD) | CotZ/CotY | Preclinical to early clinical stages | Prevention of respiratory and gastrointestinal viral infections | [88] |
RBD of (Wuhan-Hu-1 2019-nCov and Omicron B.1.1.529 variants) and the HR1-HR2 domain (Wuhan-Hu-1 2019-nCov) of the Spike protein | CotB/CotC | [89] | ||||
Influenza | Influenza virus M2 protein (M2e) | CotB | [90] | |||
Porcine reproductive and respiratory syndrome (PRRS) | PRRSV GP5 protein | CotB | [91] | |||
Transmissible gastroenteritis virus (TGEV) | TGEV spike protein | CotG | [92] | |||
Rabies virus (RABV) | Rabies virus G protein | CotG-E | [93] | |||
Duck hepatitis A virus type 1 (DHAV-1) | DHAV-1 capsid protein VP1 | CotB | [94] | |||
White Spot Syndrome Virus | VP28 protein | CotB-CotC | [95] | |||
Feline coronavirus (FCoV) | HR2-derived peptide (HR2P) from a serotype II feline enteric CoV (FECV) | CotB | [96] | |||
Enterovirus 71 (EV71) | EV71 | CotB | [97] | |||
Grass Carp Reovirus (GCRV) | antigen Vp7 GCRV | CotB/CotC | [98] | |||
Nervous necrosis virus (NNV) | Major capsid protein (MCP) of RGNNV | CotC | [99] | |||
Bacteria | Bacillus anthracis | Secreted protective antigen (PA) | CotB | Demonstrated efficacy in animal models | Immunity against anthrax | [100] |
Mycobacterium tuberculosis | Immunodominant secretory antigen, MPT64 | CotB | [101] | |||
Clostridium difficile | Flagellin protein, FliD | CotB | [102] | |||
C-terminal domains of toxin A (A26-39; codons for Ser2388 to Pro2706) or toxin B (B15-24; codons for Glu2137 to Glu2366 | CotB/CotG | [103] | ||||
Clostridium tetani | C-term fragment of the tetanus toxin, TTFC | CotB | [9] | |||
Clostridium perfringens | C-term of alpha toxin gene, Cpa247-370 fused to the GST gene | CotB | [104] | |||
Helicobacter acinonychis | Urease subunit alpha, UreA | CotG/CotZ | [105] | |||
Helicobacter pylori | Vacuolating cytotoxin A, CagA | CgeA | [106] | |||
Salmonella serovar Pullorum | OmpC | CotG | [107] | |||
Vibrio vulnificus | Vibrio antigenic protein, OmpK | CotY | [108] | |||
Mannheimia haemolytica | M. haemolytica chimeric proteins MhCP1 and MhCP2 | Non-recombinant approach | [109] | |||
Parasites | Haemonchus contortus | H. contortus glyceraldehyde-3-phosphate dehydrogenase (HcGAPDH) | CotB | Â | Prevention of parasitic infections | [110] |
Clonorchis sinensis | C. sinensis tegumental protein (CsTP22.3) | CotG | [111] | |||
C. sinensis serpin (CsSerpin) | CotC | [112] | ||||
C. sinensis enolase (Csenolase) | CotC | [113] | ||||
Paramyosin of C. sinensis (CsPmy) | CotC | [114] | ||||
Schistosoma japonicum | Glutathione S-transferase (GST) protein | CotC | [115] | |||
Plasmodium spp. | P. falciparum CSP (rPfCSP) | Non-recombinant | [116] |